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Bacterial infections of the eye highlight a dilemma that is central to all immune-privileged sites. On the one
hand, immune privilege limits inflammation to prevent bystander destruction of normal tissue and loss of
vision. On the other hand, bacterial infections require a robust inflammatory response for rapid clearance of
the pathogen. We demonstrate that the retina handles this dilemma, in part, by activation of a protective heat
shock protein. During Staphylococcus aureus-induced endophthalmitis, the small heat shock protein B-
crystallin is upregulated in the retina and prevents apoptosis during immune clearance of the bacteria. In the
absence of B-crystallin, mice display increased retinal apoptosis and retinal damage. We found that S. aureus
produces a protease capable of cleaving B-crystallin to a form that coincides with increased retinal apoptosis
and tissue destruction. We conclude that B-crystallin is important in protecting sensitive retinal tissue during
destructive inflammation that occurs during bacterial endophthalmitis.
Endophthalmitis is a vision-threatening bacterial infection
that occurs when bacteria are introduced into the posterior of
the eye following cataract surgery or a deep puncture wound.
Staphylococcus aureus is the most common cause of destructive
endophthalmitis following cataract surgery and accounts for
10% of all endophthalmitis cases (7, 12, 13, 16). Upon entering
the posterior segment of the eye, S. aureus proliferates rapidly
and produces exotoxins that directly damage retinal tissue (5,
7). In addition, the host mounts a massive neutrophil-mediated
immune response in which degranulation of neutrophils re-
leases cytotoxic mediators that further contribute to retinal-
tissue damage (7, 8, 14). Typical treatment of endophthalmitis
involves intravitreal injection of antibiotics, combined with vit-
rectomy in severe cases (7, 12). However, while intravitreal
antibiotic treatment is effective in clearing the infection, in
many cases it does not mitigate the tissue damage induced by
the bacterial exotoxins and the by-products of the host immune
response (7, 12).
The eye is an immune-privileged site where inflammation is
inhibited to preserve vision by preventing damage to the del-
icate ocular tissues (34, 41). However, immune privilege is not
absolute and can be breached, leaving the eye vulnerable to
immune-mediated inflammation. Ocular infections, in partic-
ular, can overwhelm ocular immune privilege and trigger vig-
orous inflammation within the eye, raising a very important
question (33): how does the eye protect the ocular tissues from
nonspecific damage when immune privilege is overcome and
inflammation is induced within the eye, as in the case of bac-
terial endophthalmitis? We propose that in addition to the
multiple mechanisms that inhibit inflammation, an additional
layer of immune privilege consists of special protective mech-
anisms that preserve the highly vulnerable ocular tissue when
inflammation does occur. The present study examines one of
these protective mechanisms and how it is compromised by
pathogenic bacteria.
Using a murine model of S. aureus endophthalmitis, we
identified a small heat shock protein, B-crystallin, that plays a
critical role in protecting the retina during endophthalmitis.
B-crystallin is a member of the small heat shock family of
proteins and is expressed in long-lived tissues, such as muscle,
brain, and lens (6, 9, 30, 38, 39, 42). Like other small heat shock
proteins, B-crystallin was first identified as a molecular chap-
erone that prevents aggregation of cellular proteins (21, 36,
37). More recently, B-crystallin was shown to prevent apop-
tosis by inhibiting the activation of capase 3, a protease essen-
tial for apoptosis (1, 21, 22, 23, 26, 37). Furthermore, recent
studies have demonstrated that B-crystallin is expressed in
the retina (in the ganglion cells, inner and outer nuclear layers,
inner segments, and retinal pigment epithelium), where it is
upregulated and prevents apoptosis in response to oxidative
stress (43, 44). We hypothesized that one role for B-crystallin
is to protect the delicate retinal tissue from apoptosis induced
by bacterial exotoxins, as well as bystander cell death in-
duced by the host inflammatory response during S. aureus-
induced endophthalmitis.
In the present study, we demonstrate that apoptosis is a
critical component of the pathogenesis of S.aureus-induced
endophthalmitis, leading to the loss of retinal function. In the
early response to a pathogen, B-crystallin is upregulated in
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the retina, which limits apoptosis. However, S. aureus produces
a protease that cleaves and inactivates B-crystallin, deranging
the normal response of the host and increasing retinal-cell
vulnerability to apoptosis. This study illuminates a novel pro-
tective mechanism used by the host to prevent retinal damage
during endophthalmitis and identifies a new role for a protease
of S. aureus in the pathogenesis of infection.
MATERIALS AND METHODS
Animals. Female C57BL/6J mice were purchased from the Jackson Laboratory
(Bar Harbor, ME). Male and female 129S6/SvEvTac control mice were pur-
chased from Taconic Farms (Germantown, NY). The B-crystallin knockout
(KO) mice (129S6/SvEvTac) were obtained from the National Eye Institute (6).
The genotypes of the B-crystallin KO mice were confirmed by PCR according
to a previously published protocol (6). All animals were treated according to the
guidelines of the Association for Research in Vision and Ophthalmology Reso-
lution on the Use of Animals in Research. All procedures involving mice were
approved by the Schepens IACUC.
Induction of endophthalmitis. Mice received an intravitreal injection of 0.5 l
of sterile physiological saline (Hospira, Lake Forest, IL), in which 500 or 5,000
CFU S. aureus (strain RN6390) were suspended, into the left eye according to a
previously described protocol (13). Briefly, the bacteria were grown for 4.5 h at
37°C with shaking to log phase and diluted to the appropriate concentrations. An
intravitreal injection of S. aureus, just posterior to the limbus-parallel conjunc-
tival vessels, was performed using a borosilicate microcapillary pipette pulled to
a tip size of 50 m. The right eye of each mouse was untreated and served as an
internal control for electroretinography (ERG) studies. Before injection, S.
aureus was grown in standard Bacto brain heart infusion (BHI) broth (BD
Bioscience, Sparks, MD), harvested in log phase, and diluted in physiological
saline to 500 CFU/0.5 l or 5,000 CFU/0.5 l.
Clinical scoring. At 24, 48, 72, and 96 h following injection, clinical examina-
tions were performed by slit lamp biomicroscopy. The mice were assigned a
clinical score of 0 to 3, with a clinical score of 0 corresponding to a clear anterior
chamber, clear vitreous, and clear view of the retina; 1 corresponded to mild
aqueous flare, mild vitreal haze, and the view of the retina slightly obscured; 2
corresponded to moderate aqueous flare, dense vitreal haze, poor pupil dilation,
and the view of the retina moderately obscured; 3 represented intense aqueous
flare, opaque vitreous, and the view of the retina completely obscured.
Histological analysis. Mice were euthanized at 24, 48, 72, and 96 h following
injection, and following euthanasia, the eyes were enucleated using Stevens
curved sharp-tip scissors. The eyes were fixed in 10% buffered formalin, embed-
ded in paraffin, sectioned, and stained with hematoxylin and eosin (HE). Apop-
totic cells were identified using a terminal deoxynucleotidyltransferase-mediated
dUTP-biotin nick end labeling (TUNEL) in situ cell death detection kit (TMR
red; Roche Applied Science). The sections were mounted using DAPI (4,6-
diamidino-2-phenylindole) pannuclear stain (Vectashield). Following staining,
the ratio of TUNEL-positive to total DAPI-positive cells was calculated in six
visual fields at 100 magnification. These calculations were repeated in three
sections per experimental eye, with at least four animals per group per time
point. An anti-CD45 antibody was used to distinguish bone marrow-derived
inflammatory cells from the resident cells of the retina. Some slides were double
stained with TUNEL and anti-CD45 staining. CD45 staining was performed
using a three-step staining procedure with rat anti-mouse CD45 antibody (BD
Biosciences, San Jose, CA), biotin-conjugated anti-rat immunoglobulin G2b (BD
Bioscience, Sparks, MD) as the secondary antibody, and streptavidin-horseradish
peroxidase (BD Bioscience, Sparks, MD), together with the DAB detection
system (Vector Laboratories, Burlingame, CA).
Intraocular bacterial quantification. Mice were euthanized at 24, 48, 72, and
96 h following injection, and the eyes were enucleated as described above. The
eyes were placed in 1.0 ml sterile phosphate-buffered saline on ice and homog-
enized by bead beating (FastPrep FP120; Thermo Fisher Scientific, Waltham,
MA) with 1.0-mm glass beads for 90 seconds at maximum speed. The homoge-
nates were serially diluted and plated on BHI agar plates.
ERG. ERG was performed on the mice at 24, 48, 72, and 96 h postinoculation
using a slightly modified protocol (13). Briefly, the mice were dark adapted for
at least 4 h. The mice were then anesthetized, and the pupils were dilated using
1% tropicamide ophthalmic solution (Bausch & Lomb, Tampa, FL). Following
anesthesia, the body temperature was maintained at 37°C using a microwave heat
pad. Gold wire electrodes (0.25 mm; Alfa Aesar, Ward Hill, MA) were placed on
the cornea after application of a hypromellose ophthalmic prism solution
(Akorn, Inc.) and connected to a visual electrodiagnostic system (UTAS-E 3000;
LKC Technologies, Gaithersburg, MD). Needle electrodes placed in the anterior
scalp and the tail served as reference and ground leads, respectively. The b-wave
amplitude (measured from the trough of the a-wave to the peak of the b-wave)
in response to a bright flash in a Ganzfeld illumination sphere was recorded for
the injected left eye and the contralateral (internal-control) right eye simulta-
neously. A total of 30 readings at 0.6 cd-s/m2 flash intensity with a 1-second
interval between flashes were taken and averaged. The retinal function was
defined as the ratio of the b-wave amplitude (from the trough of the a-wave to
the peak of the b-wave) of the experimental treated eye divided by the value for
the contralateral untreated eye.
Posterior-segment protein analysis. Mice were euthanized at 24, 48, 72, and
96 h following injection, and following euthanasia, the eyes were enucleated and
snap-frozen in liquid nitrogen; eyes that received no injections were enucleated
as 0-h controls. The eyes were dissected frozen in a cold room on dry ice, and the
posterior segment (vitreous, retina, retinal pigment epithelium, sclera, choroids,
and optic nerve) of each eye was collected. Posterior segments were homoge-
nized in 8 M urea/2% CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-1-
propanesulfonate} buffer with 1 Complete minicocktail protease inhibitor
(Roche Applied Science, Indianapolis, IN). The protein concentration was quan-
tified using a Bio-Rad DC protein assay (Bio-Rad Laboratories, Hercules, CA).
Posterior-segment proteins were analyzed by Western blotting. The proteins
were separated on 12% Tris-glycine gels (Invitrogen, Carlsbad, CA) and trans-
ferred onto Invitrolon polyvinylidene difluoride membranes (Invitrogen, Carls-
bad, CA). The membranes were blocked with 5% milk and probed for B-
crystallin, caspase 3, and actin using monoclonal mouse anti-B-crystallin (Assay
Designs, Ann Arbor, MI), polyclonal rabbit anti-cleaved caspase 3 (Cell Signal-
ing Technology, Danvers, MA), and polyclonal goat anti-actin (Santa Cruz Bio-
technology, Santa Cruz, CA) with the appropriate secondary antibodies (Santa
Cruz Biotechnology, Santa Cruz, CA): goat anti-mouse, goat anti-rabbit, and
bovine anti-goat, respectively.
In vitro B-crystallin assay. Recombinant B-crystallin (50 ng) (Assay De-
signs, Ann Arbor, MI) was incubated overnight with 24 l of either (i) sterile
BHI broth (Becton, Dickinson and Company, Sparks, MD), (ii) nonsterile S.
aureus supernatant, or (iii) nonsterile S. aureus supernatant with 1 Complete
minicocktail protease inhibitor (Roche Applied Science, Indianapolis, IN). Sam-
ples were analyzed by Western blotting and probed using monoclonal mouse
anti-B-crystallin with goat anti-mouse secondary antibody, as described above.
Statistical analysis. Where normally distributed, the data were analyzed with
an unpaired t test with a P value of 0.05 as the basis for rejection of the null
hypothesis; nonparametric data were analyzed using a Mann-Whitney U test.
Where appropriate, the Q test was used to eliminate one outlier per experimen-
tal group. Statistical analysis and graphing were performed using Prism and
Microsoft Excel.
RESULTS
Induction of bacterial endophthalmitis. We used a murine
model of S. aureus-induced endophthalmitis (13) to determine
whether B-crystallin plays a significant role in protecting oc-
ular tissue from apoptosis in response to infection. Since the S.
aureus endophthalmitis model was developed recently, the first
series of experiments served as an independent confirmation
that the laboratory model was reproducible.
Similar to what was previously reported, eyes infected with
500 CFU of S. aureus developed a mild infection in which the
intraocular bacterial load peaked at 48 h (maximum, 1.6  104
CFU/eye) but the infection was cleared by 96 h in 85% of the
mice, resulting in destruction of the eyes in only 15% of the
mice (Fig. 1). By contrast, eyes infected with 5,000 CFU of S.
aureus developed a progressive infection that increased in se-
verity over 96 h (maximum, 1.4  107 CFU), resulting in
complete destruction of the eyes in 70% of the mice. As ex-
pected, no ocular damage was observed in the control mice
that received an intravitreal injection of sterile saline.
In the eyes of mice that cleared an infection of 500 CFU of
S. aureus, slit lamp examinations revealed minimal corneal
opacity and poor pupil dilation that peaked at 48 h and sub-
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sequently resolved (Fig. 2). Histological analysis revealed mild
inflammation with a minimal vitreous infiltrate at 24 and 48 h
that resolved and coincided with slight retinal folding in the
inner and outer nuclear layers. By contrast, mice that received
5,000 CFU of S. aureus displayed severe inflammation, char-
acterized by significant corneal opacity, corneal edema, and
poor pupil dilation within 48 h. Histological analysis revealed a
robust inflammatory infiltrate, retinal hemorrhaging, severe
retinal folding, and visible bacterial growth in the vitreous at 24
to 48 h with complete destruction of the retina by 72 to 96 h
(Fig. 2). Control mice receiving an injection of sterile saline did
not exhibit any signs of inflammation at any time postinjection
(Fig. 2).
Retinal function, as determined by the b-wave amplitude
measured by ERG, corresponded with the clinical and histo-
logical findings. Control mice that received sterile-saline intra-
vitreal injections displayed a transient loss of retinal function at
24 h postinjection, returning to 91% of normal by 96 h (Fig.
3B). Mice that received 500 CFU of S. aureus displayed a loss
in retinal function to 48% of normal at 24 h that returned to
83% of normal by 96 h as the bacterial infection was cleared.
By contrast, mice that received 5,000 CFU of S. aureus dis-
played a complete loss of retinal function at 24 h that never
recovered. Representative ERG recordings at 96 h revealed a
total loss of the b-wave amplitude in eyes that received 5,000
CFU of S. aureus; by contrast, mouse eyes that received 500
CFU of S. aureus displayed 83% of the normal (contralateral-
eye) b-wave amplitude at 96 h (Fig. 3A).
FIG. 1. Clinical examination and bacterial quantification. C57BL/6J mice received intravitreal injections of either sterile saline or 500 CFU or
5,000 CFU S. aureus. (A) Eyes were examined by slit lamp and given a score of 0, 1, 2, or 3 (0, cleared, and 3, destroyed). At 96 h, 70% of eyes
receiving 5,000 CFU and 15% of eyes receiving 500 CFU were destroyed (score, 3). Sterile saline, n  9; 500 and 5,000 CFU, n  30;  P  0.001.
(B) The bacterial load in eyes injected with 500 CFU peaked at 48 h (1.6 104 CFU/eye); eyes injected with 5,000 CFU did not clear the infection,
and the bacterial load increased to 1.4  107 at 72 h. No bacteria grew in eyes injected with sterile saline at any time point. Saline, n 3; 500 CFU,
n  9; 5,000 CFU, n  9; , P  0.0001; , P  0.01.
FIG. 2. Representative clinical pictures and histology. C57BL/6J mice received intravitreal injections of either sterile saline or 500 CFU or 5,000
CFU S. aureus. At 24, 48, 72, and 96 h, the eyes were photographed and then removed, sectioned, and stained for HE. Mild inflammation was
observed in eyes that received 500 CFU, and severe retinal damage was observed in eyes that received 5,000 CFU. Retinal detachment in saline-
and 500-CFU-injected eyes is an artifact of tissue sectioning. HE pictures were taken of whole eyes at 2 magnification, and the retina at 20
magnification. C, cornea; L, lens; R, retina; V, vitreous; IP, inner plexiform; INL, inner nuclear layer; ONL, outer nuclear layer.
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Expression of B-crystallin during endophthalmitis. To de-
termine whether B-crystallin was upregulated during endoph-
thalmitis, the posterior segment of each eye was isolated fol-
lowing an intravitreal injection of either saline or 500 or 5,000
CFU of S. aureus. Eyes that did not receive an intravitreal
injection (0 h) yielded a 22-kDa B-crystallin band (Fig. 4A).
Interestingly, an intravitreal injection of sterile saline alone
induced a significant increase in B-crystallin expression that
peaked at 48 h (more than 250% of the unperturbed normal
eye) and remained elevated at 96 h. This up-regulation of
B-crystallin at 48 h coincided with the recovery of retinal
function (Fig. 3B and 4B). Mice that received 500 CFU of S.
aureus displayed a similar upregulation of B-crystallin at 48 h
postinfection, but a smaller, 18-kDa B-crystallin band began
to appear at 72 h (Fig. 4A and B). However, the 18-kDa band
was always expressed at much lower levels than full-length
(22-kDa) B-crystallin. This smaller, 18-kDa band may repre-
sent a cleavage product of B-crystallin. By contrast, in mice
that received 5,000 CFU of S. aureus, the 22-kDa B-crystallin
band decreased below baseline expression at 72 and 96 h
postinfection, and the smaller, 18-kDa band increased steadily
from 24 to 96 h, so that the level of the 18-kDa B-crystallin
was significantly higher (P  0.05) than the level of full-length
(22-kDa) B-crystallin. The increase in the 18-kDa band co-
incided with the increase in the bacterial load and retinal
damage in these eyes. These data imply that the upregulation
of full-length B-crystallin is associated with retinal protection,
while cleavage of B-crystallin is associated with retinal de-
struction and loss of retinal function.
Expression of active caspase 3. Recent studies demonstrated
that B-crystallin prevents apoptosis by binding to caspase 3
and directly blocking its activation (21, 22, 23). B-crystallin
can also indirectly block the activation of caspase 3 by (i)
binding to the proapoptotic factors Bax and Bcl-X(S), (ii)
preventing their translocation into the mitochondria, and (iii)
restricting the release of cyochrome c (27). Both the direct and
indirect antiapoptotic activities may be terminated if B-crys-
tallin is cleaved. The next series of experiments determined
whether the loss of full-length B-crystallin (the 22-kDa band)
and the appearance of the smaller (18-kDa band) B-crystallin
protein coincided with the activation of caspase 3. Western
blot analysis was performed on the posterior-segment protein
lysates using a caspase 3-specific antibody that recognizes only
the active form of caspase 3. As predicted, there was no de-
tectable active caspase 3 at any time point in the eyes of mice
receiving either sterile saline or 500 CFU of S. aureus (Fig.
4D). However, the percentage of eyes expressing active
caspase 3 in mice receiving 5,000 CFU of S. aureus increased
FIG. 3. ERG assessment of retinal function. C57BL/6J mice received intravitreal injections of sterile saline or 500 CFU or 5,000 CFU S. aureus.
(A) Representative ERG response to 0.6 cd-s/m2 flash intensity at 96 h following 500 CFU or 5,000 CFU S. aureus injection (right and left,
respectively). The b-wave amplitude (from the trough of the a-wave [i] to the peak of the b-wave [ii]) was determined, and the ratio of injected
eye to contralateral internal control eye was calculated. (B) The 5,000-CFU group lost all retinal function, while the 500-CFU and saline groups
displayed only a transient loss of retinal function. The data are expressed as percent retinal function in the experimental left eye compared to the
control right eye. Saline, n  3; 500 CFU, n  10; 5,000 CFU, n  10. , P  0.001 for 5,000 CFU versus saline and 5,000 CFU versus 500 CFU.
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steadily following the intravitreal injections (Fig. 4C), so that
by 96 h, 60% of the mice expressed active caspase 3 (Fig. 4D).
The appearance of active caspase 3 beginning in eyes that
received 5,000 CFU at 48 h coincided with the increased level
of the smaller, 18-kDa B-crystallin band and the decrease in
the full-length 22-kDa band, suggesting that the antiapoptotic
activity of B-crystallin may be lost when it is cleaved.
In vitro cleavage of B-crystallin. S. aureus also produces a
variety of exotoxin proteases that contribute to virulence and
are capable of breaking down both host and pathogen matrix
proteins (5, 10, 24, 40). The best-studied S. aureus extracellular
proteases include SspA, SspB, and aureolysin, which have been
linked to virulence and are involved in activating other exo-
toxins (40). In order to determine whether S. aureus produces
an exotoxin that cleaves B-crystallin, recombinant B-crystal-
lin was incubated overnight with an S. aureus supernatant and
analyzed by Western blotting. The data in Fig. 5 reveal that S.
aureus produces a protease that cleaves recombinant B-crys-
tallin in vitro, and the cleavage band (18 kDa) was the same
size as the band observed in the posterior segments of mice
receiving 5,000 CFU of S. aureus. The addition of a protease
inhibitor cocktail to the S. aureus supernatant blocked the cleav-
age and formation of the 18-kDa band (Fig. 5). These data indi-
cate that an extracellular protease produced by S. aureus cleaves
B-crystallin in vitro and imply that a similar cleavage may occur
in vivo during bacterial endophthalmitis.
To determine the protease class responsible for cleaving
B-crystallin, recombinant B-crystallin was incubated over-
night with an S. aureus supernatant in the presence or absence
of specific inhibitors of serine, cysteine, or metalloproteases
(Pefabloc SC, E-64, and EDTA, respectively). Unexpectedly,
all three protease inhibitors blocked the cleavage of B-crys-
tallin (data not shown), indicating that a complex network of
proteases are involved in cleaving B-crystallin.
FIG. 4. Expression of B-crystallin and active caspase 3. C57BL/6J mice received intravitreal injections of sterile saline or 500 CFU or 5,000
CFU S. aureus. (A) Representative Western blot results probing for B-crystallin (22 kDa) and actin (43 kDa) loading control. Two samples per
group per time point are shown. (B) Densitometry of Western blot results, probing for B-crystallin. The data are shown as the mean
[(B-crystallin/actin) injected sample]/[(B-crystallin/actin) normal control]. Saline, n  3; 500 CFU, n  4; 5,000 CFU, n  5. Standard error of
the mean: , P  0.05 for 5,000 versus saline or 500 CFU full B-crystallin. (C) Representative Western blot results using an active caspase
3-specific antibody in eyes that received 5,000 CFU S. aureus. (D) Percentages of eyes by Western blot analysis expressing active caspase 3 at 24,
48, 72, and 96 h in C57BL/6J mice following sterile-saline or 500- or 5,000-CFU S. aureus injection. Saline, n  3; 500 CFU, n  4; 5,000 CFU,
n  5.
FIG. 5. Cleavage of recombinant B-crystallin by S. aureus super-
natant. Western blot analysis of recombinant B-crystallin treated with
(i) sterile BHI broth, (ii) S. aureus culture supernatant, or (iii) S. aureus
culture supernatant plus protease inhibitor cocktail.
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Retinal apoptosis during endophthalmitis. Our data indi-
cate that cleavage of B-crystallin coincides with increased
activation of caspase 3. Therefore, we predicted that the loss of
the full-length B-crystallin and subsequent increase in the
cleaved B-crystallin would correspond with increased apop-
tosis in the retina. Retinal apoptosis following intravitreal in-
fection was determined by TUNEL staining of retinal sections.
TUNEL staining identified very few apoptotic cells in retinas
of eyes that received either sterile saline or 500 CFU of S.
aureus. The proportion of cells in the retina undergoing apop-
tosis never increased above 2 to 3% of total cells (Fig. 6A and
B). However, the fraction of apoptotic cells in the retina in-
creased steadily in mice that received 5,000 CFU, with 9%
apoptotic retinal cells at 24 h, peaking at 16% at 72 h.
Double staining with an anti-CD45 antibody revealed that
the cells undergoing apoptosis in the saline and 500-CFU
groups were primarily CD45-positive (CD45) infiltrating in-
flammatory cells (Fig. 7). By contrast, the cells undergoing
apoptosis in the retinas of the mice that received 5,000 CFU
were primarily CD45 negative. We conclude that during de-
structive bacterial endophthalmitis, cleavage of B-crystallin
coincides with increased retinal-cell apoptosis.
Endophthalmitis in B-crystallin KO mice. Our data dem-
onstrate that increased expression of B-crystallin coincides
with reduced retinal apoptosis and reduced retinal damage,
while cleavage of B-crystallin coincides with increased retinal
apoptosis and increased retinal damage. Based upon these
data, we hypothesize that upregulation of full-length B-crys-
tallin is required for prevention of apoptosis in the retina and
preservation of retinal function, even during infections that are
successfully cleared. To test this hypothesis, we compared the
development of bacterial endophthalmitis in B-crystallin KO
mice with that in wild-type mice that received intravitreal in-
jections of 500 CFU of S. aureus.
B-crystallin KO mice and wild-type mice displayed no sig-
nificant difference in their ability to clear an infection of 500
CFU of S. aureus. Seventy-seven percent of the eyes from
B-crystallin KO mice and 83% of the eyes from wild-type
mice cleared the infection by 96 h (Fig. 8A). Clearance of the
bacteria was confirmed by determining the bacterial load at
96 h (data not shown). Interestingly, although there was no
difference in the ability to clear the bacteria in B-crystallin
KO mice, retinal function was significantly reduced (P  0.05)
at 48 h in B-crystallin KO eyes (49% of normal) compared
with wild-type eyes (69% of normal), and they were slower to
recover retinal function (Fig. 8B). To determine whether the
difference in retinal function at 48 h was due to increased
retinal apoptosis in B-crystallin KO mice, histological sec-
tions of eyes from wild-type and B-crystallin KO mice were
double stained for TUNEL and CD45 at 48 h postinfection.
Increased levels of apoptosis of CD45-negative cells were ob-
served in the retinas of B-crystallin KO mice compared with
the wild-type control mice (Fig. 8C). Apoptosis in the B-
crystallin KO eyes was concentrated in pockets and coincided
FIG. 6. Retinal apoptosis during endophthalmitis. C57BL/6J mice received intravitreal injections of either sterile saline or 500 CFU or 5,000
CFU S. aureus. (A) Representative TUNEL staining (10 magnification) in C57BL/6J mouse retinas (red fluorescence signifies TUNEL staining).
No apoptosis was observed in mice receiving saline injections. Very little apoptosis (i) was observed at any of the time points in mice receiving 500
CFU. High levels of apoptosis were observed in the inner nuclear layer at 24 to 48 h (ii) and throughout the retina at 72 to 96 h (iii) in mice
receiving 5,000 CFU S. aureus. V, vitreous; INL, inner nuclear layer; ONL, outer nuclear layer; SC, sclera/choroid. (B) Percentages of TUNEL-
positive cells in the retina. Saline, n  2; 500 CFU, n  4; 5,000 CFU, n  5.
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with increased retinal damage, as demonstrated by retinal folds
and hemorrhaging. However, at 48 h postinjection of saline
alone, no apoptosis was observed in the retinas of wild-type or
B-crystallin KO mice. The results from the saline controls
indicated that an intravitreal injection of saline alone did not
induce apoptosis in either the wild-type or the B-crystallin
KO mice. Therefore, the increased apoptosis observed in the
retinas of B-crystallin KO mice was specifically induced by
the bacterial infection and not by the intravitreal injection
alone. Together, these data indicate that B-crystallin prevents
retinal apoptosis during a bacterial infection and that in the
absence of B-crystallin, there is increased apoptosis and in-
creased retinal damage, which occur even when the bacterial
infection is successfully cleared.
DISCUSSION
Our studies identified upregulation of B-crystallin as a de-
fense mechanism of the immune-privileged eye that protects
delicate retinal tissue from bacterial and host-mediated by-
stander damage, as occurs during S. aureus endophthalmitis.
Furthermore, our studies revealed that S. aureus produces a
protease capable of cleaving B-crystallin into a form identi-
fied as being ineffective in preventing retinal apoptosis and
destructive endophthalmitis.
A unique property of the eye is the ability to protect against
pathogens while simultaneously protecting the delicate visual
axis from the sight-destroying effects of immunogenic inflam-
mation (for a review, see reference 41). This property is called
immune privilege and was first described by Medawar in 1948.
Medawar demonstrated that foreign tissue allografts survive
for a prolonged period of time in immune-privileged sites such
as the eye, whereas placement of identical allografts at con-
ventional (nonprivileged) body sites led to immune rejection
(28). Work over the last several decades has revealed that
ocular immune privilege restricts both adaptive and innate
immune effectors in a way that balances the challenge of
pathogenic infection against the challenge of inflammation-
induced vision loss (41). The present study shows that B-
crystallin contributes to the protection of the retina from the
inflammatory effects of infection and that this protection is
undermined by S. aureus, a leading cause of severe endoph-
thalmitis.
A member of the small heat shock protein family, B-crys-
tallin was first identified as a lens protein involved in maintain-
ing lens clarity (18). However, in 1989, Bhat and Nagineni and
Dubin et al. demonstrated extralenticular expression of crys-
tallin (4, 11). Over the last decade, several investigators dem-
onstrated that B-crystallin is an important molecular chaper-
one that is induced by a variety of stress stimuli and confers
cellular protection by suppressing the nonspecific aggregation
of denatured proteins (17, 25). More recently, studies have
demonstrated that B-crystallin also inhibits apoptosis by
blocking the proteolytic activation of caspase 3 (21, 22). Fur-
thermore, while B-crystallin is expressed constitutively within
the neural retina and retinal pigment epithelium, oxidative
stress dramatically increases the level of expression (43, 44). In
vitro studies have demonstrated that overexpression of B-
crystallin in retinal pigment epithelium cells coincides with
reduced caspase 3 activity and apoptosis in response to oxida-
tive stress (44). These studies imply that upregulation of B-
crystallin in the retina amplifies resistance to cell death, allow-
ing the cells to adapt to changes in their environment and to
survive otherwise-lethal conditions.
In this model of S. aureus-induced endophthalmitis, the an-
tiapoptotic effect of B-crystallin was most evident during a
mild infection of the eye that was successfully cleared by the
FIG. 7. TUNEL and CD45 double staining. C57BL/6J mice received intravitreal injections of either sterile saline or 500 CFU or 5,000 CFU
S. aureus. The open arrows indicate apoptosis of infiltrating CD45-positive immune cells; the closed arrows indicate apoptosis of CD45-negative
retinal cells. Magnification, 10. V, vitreous; INL, inner nuclear layer; ONL, outer nuclear layer; SC, sclera/choroid.
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immune system. An intravitreal injection of 500 CFU of S.
aureus induced a low level of inflammation, as well as upregu-
lation of B-crystallin in the retina. The inflammatory re-
sponse successfully cleared the infection within 72 h with little
apoptosis. Studies using the B-crystallin KO mice further
confirmed the protective effects of B-crystallin. While B-
crystallin KO mice did not show impaired ability to clear in-
fection, KO mice showed increased retinal damage and apop-
tosis compared to wild-type mice.
In addition to demonstrating the role of B-crystallin in
protecting the retina during infection, we also identified a
novel mechanism by which S. aureus may impede this protec-
tion. The heat shock protein B-crystallin is constitutively ex-
pressed in the retina and, as others have demonstrated, is
upregulated in response to many forms of stress (43, 44). How-
ever, unique to our studies is the finding that S. aureus pro-
duces a protease that cleaves and inactivates B-crystallin, thus
eliminating its protective effect. When the host did not readily
clear an S. aureus infection, we observed that retinal B-crys-
tallin was cleaved, and this cleavage coincided with increased
retinal apoptosis, significant tissue damage, and loss of retinal
function. The cleavage of B-crystallin was observed only fol-
lowing infection with S. aureus, and no cleavage of B-crystal-
lin was observed in wild-type mice treated with saline alone. In
addition, in vitro studies determined that S. aureus produced
one or more proteases that cleave B-crystallin. Although we
have not elucidated the cleavage site, based on the molecular
weight of the cleavage product, we predict that cleavage occurs
in either the N-terminal or the C-terminal domain of B-
crystallin, which are involved in oligomerization and solubility
of oligomers, respectively (23, 32). The data from Kamradt et
al. indicates that, if the oligomerization of B-crystallin is im-
paired (by N-terminal domain mutation), then this impaired
form of B-crystallin allows increased activation of caspase 3
and increased apoptosis (23). Therefore, if the cleavage of
B-crystallin observed in infected retinas interferes with N-
terminal oligomerization, then this will coincide with increased
caspase 3 activation and increased apoptosis. These data reveal
another pathogenic mechanism by which S. aureus increases
the vulnerability of retinal cells to apoptotic cell death. Con-
ceivably, other endophthalmitis pathogens, such as Pseudomo-
nas and Bacillus, produce proteases with similar activities.
These data also raise important questions about the pathogen-
esis of S. aureus endophthalmitis. Specifically, how do bacteria
FIG. 8. Clinical examination, bacterial clearance, and retinal apoptosis. B-crystallin KO and wild-type mice received 500-CFU S. aureus
intravitreal injections. (A) Eyes were examined by slit lamp and given a score of 0, 1, 2, or 3 (0, cleared, and 3, destroyed). At 96 h, there was no
significant difference in percentages of destroyed (score, 3) eyes (23% of B-crystallin KO; 17% of wild-type). (B) Retinal function, as determined
by ERG, was significantly depressed at 48 h (49% of normal) in B-crystallin KO mice compared to wild-type controls (69% of normal) (n  10;
, P  0.05). (C) HE and TUNEL staining in eyes enucleated at 48 h revealed increased retinal folding and bleeding (circled in 10 HE image)
and retinal apoptosis in B-crystallin KO mice compared to the wild type (closed arrows, CD45 negative). Low levels of CD45-positive
inflammatory-cell apoptosis were observed in both wild-type and KO eyes (open arrows, CD45 positive). No apoptosis was observed in wild-type
or B-crystallin KO mice that received saline only. C, cornea; L, lens; R, retina; V, vitreous; INL, inner nuclear layer; ONL, outer nuclear layer;
SC, sclera/choroid.
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induce apoptosis of cells in the retina? Bantel et al. reported that
S. aureus induces apoptosis in Jurkat cells in vitro without bacte-
rial internalization (2). This was accomplished via the release of
the bacterial toxin alpha-toxin, which forms pores within the
plasma membranes of target cells (2). Genestier and colleagues
identified another pore-forming toxin, Panton-Valentine leukoci-
din (PVL), which induces apoptosis in neutrophils (15). Genestier
proposed that PVL forms large pores in the membranes of neu-
trophils, resulting in necrosis. They hypothesized, however, that
sublytic concentrations of PVL form a few small pores that allow
the entry of S. aureus-derived toxins and proteases. This induced
apoptosis via the intrinsic death pathway, in which cytochrome c
was released within the mitochondria, triggering the pathway that
leads to the activation of downstream caspases, such as caspase 3.
Support for the prospect that S. aureus is capable of introducing
protein factors that manipulate the biology of target cells stems
from the observation that the S. aureus C3-like ADP-ribosyltrans-
ferase is capable of accessing its intracellular substrate in an oth-
erwise-intact cell (31). However, B-crystallin inhibits the activa-
tion of caspase 3, increasing the resistance of retinal cells to
apoptosis. We propose that cleaved B-crystallin is nonfunctional
and unable to prevent activation of caspase 3. Therefore, entry of
the protease into retinal cells through mechanisms such as mem-
brane pores could lead to cleavage of B-crystallin, making the
retinal cells more susceptible to the apoptosis that is triggered by
S. aureus toxins, such as alpha-toxin and PVL.
Alternatively, S. aureus may induce apoptosis following in-
ternalization into retinal cells. While S. aureus is not generally
considered an intracellular pathogen, many host cells, includ-
ing corneal epithelial cells, internalize S. aureus (19). Further-
more, internalization of S. aureus can induce apoptosis in many
cell types, including epithelial cells, endothelial cells, and ke-
ratinoyctes (3, 20, 29, 35). If retinal cells internalize S. aureus,
bacterial toxins and the proteases could be released through
pores in a phagocytic vacuole, potentially making the cell more
vulnerable to apoptosis. Studies are ongoing in our laboratory
to (i) identify the S. aureus-derived protease that cleaves B-
crystallin and (ii) determine whether retinal cells internalize S.
aureus during endophthalmitis and/or whether S. aureus se-
cretes bacterial toxins that enter retinal cells through mem-
brane pores.
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